サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1433613

In-vitro（体外）毒性試験の世界市場規模、シェア、動向分析レポート：技術別、最終用途別、用途別、方法別、製品別、地域別、セグメント別予測（2024年～2030年）

In-vitro Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture, High Throughput), By End-use, By Application, By Method (Cellular Assay), By Product, By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 117 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.89円
In-vitro（体外）毒性試験の世界市場規模、シェア、動向分析レポート：技術別、最終用途別、用途別、方法別、製品別、地域別、セグメント別予測（2024年～2030年）
出版日: 2024年01月23日
発行: Grand View Research
ページ情報: 英文 117 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

In-vitro（体外）毒性試験市場の成長と動向：

世界のIn-vitro（体外）毒性試験の市場規模は、2030年までに648億1,000万米ドルに達し、2024年～2030年にCAGR11.17％で拡大すると予測されています。 長年にわたり、規制当局によるIn-vitro（体外）毒性試験法の受け入れは速いペースで増加しており、その結果、従来の試験とは対照的に、これらの試験法の検証はさらに高まっています。

また、毒性試験の動物実験を代替する技術の開拓が、In-silicoシミュレーション、アッセイ、3D細胞培養などの体外モデルの利用を促進し、市場の成長を後押ししています。

新薬候補のスクリーニングには、前臨床試験に動物を使用する必要がありますが、これは非常に面倒でコストがかかります。しかし、最近では、動物を用いた化学物質試験の禁止を推進する国も出てきています。例えば、EUは数年前から動物実験の削減、代替、改良を推進しています。化粧品に関する規則（1223/2009）、REACH（2007/2006）、科学的目的のために使用される動物の保護に関する指令（2010/63）、分類・表示・包装（CLP）（1272/2008）などは、動物毒性試験の代替を強く奨励するEU法の一例です。さらに2018年6月には、カリフォルニア州で2020年以降の動物実験製品の販売を禁止する「Cruelty-Free Cosmetics Act」が成立しました。

多くの政府や民間団体が、従来の試験モデルを最小化し、In-vitro（体外）毒性試験法を支援・開発するための資金を提供し、政府の政策を促進するための行動をとっています。このように、動物実験を禁止することに重点を置いた政府のイニシアティブの増加は、体外毒性学的モデルの採用増加の原因となり、市場内に多くの機会を作り出しています。例えば、動物の倫理的扱いを求める人々の会（PETA）とその国際的な関連団体は、非動物実験法の開発を促進するために約320万米ドルを拠出しました。

生物学的手法、ハイスループット手法、化学的手法などの計算およびスクリーニング手法の進歩は、毒性解析のための膨大な数の公開データベースと相まって、大きく拡大しました。これにより、研究者は創薬研究、毒性プロファイリング、医薬品開発プログラムのための情報にアクセスできるようになりました。例えば、Agilent Technologies, Inc.のMetaTox HSプロジェクトは、医薬品開発手順における毒性アッセイと高感度代謝のための高度なソリューションを提供しています。

In-vitro（体外）毒性試験市場レポートハイライト：

  • 技術別では、細胞培養技術セグメントが2023年の世界市場で43.88%の市場シェアを占め、これは正確で費用対効果の高い分析に対する需要の高まりによるものです。さらに、3D細胞培養の採用もこのセグメントの成長を促進しています。
  • 用途別では、全身毒性学用途分野が2023年の市場を独占しました。最小用量、耐容用量、リスク評価など、毒性学的データポイントの生成が収益創出に貢献しています。
  • 細胞アッセイは、細胞ベースのイメージングアッセイ、ハイスループットスクリーニング、ラベルフリー検出の開発により、収益面で最大のシェアを占め、予測期間中に成長する見込みです。
  • 2023年の市場では、製薬産業の最終用途セグメントが大きなシェアを占めていました。医薬品開発段階における毒性試験の重要性は、製品パイプラインの多さと相まって、収益創出の要因となっています。
  • 北米が市場を独占し、2023年には47.73%のシェアを占めましたが、これは動物実験禁止の普及と毒物学研究に対する政府の支援策によるものです。また、同地域では、体外試験製品やサービスを提供する企業が集結しており、予測期間中も収益創出が続くとみられます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 In-vitro（体外）毒性検査市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • In-vitro（体外）毒性試験市場分析ツール
    • ポーターの分析
    • PESTEL分析
    • 価格分析

第4章 In-vitro（体外）毒性試験市場：技術の推定・動向分析

  • セグメントダッシュボード
  • In-vitro（体外）毒性試験市場：技術の変動分析（2023年・2030年）
  • 細胞培養技術
  • ハイスループット技術
  • 分子イメージング
  • オミックステクノロジー

第5章 In-vitro（体外）毒性試験市場：製品の推定・動向分析

  • セグメントダッシュボード
  • In-vitro（体外）毒性試験市場：製品の変動分析（2023年・2030年）
  • 消耗品
  • アッセイ
  • 機器
  • ソフトウェア
  • サービス

第6章 In-vitro（体外）毒性試験市場：用途の推定・動向分析

  • セグメントダッシュボード
  • In-vitro（体外）毒性試験市場：用途の変動分析（2023年・2030年）
  • 全身毒性
  • 経皮毒性
  • 内分泌かく乱
  • 眼毒性
  • その他の毒性

第7章 In-vitro（体外）毒性試験市場：方法の推定・動向分析

  • セグメントダッシュボード
  • In-vitro（体外）毒性試験市場：方法の変動分析（2023年・2030年）
  • 細胞アッセイ
  • 生化学的アッセイ
  • In-silico
  • Ex-vivo

第8章 In-vitro（体外）毒性試験市場：最終用途の推定・動向分析

  • セグメントダッシュボード
  • In-vitro（体外）毒性試験市場：最終用途の変動分析（2023年・2030年）
  • 製薬産業
  • 化粧品および家庭用品
  • 学術機関および研究機関
  • 診断
  • 化学工業
  • 食品業界

第9章 In-vitro（体外）毒性試験市場：地域の推定・動向分析

  • In-vitro（体外）毒性試験市場シェア：地域別（2023年・2030年）
  • 北米
    • 北米のIn-vitro（体外）毒性試験市場の推定・予測（2018年～2030年）
    • 米国
    • カナダ
  • 欧州
    • 欧州のIn-vitro（体外）毒性試験市場の推定・予測（2018年～2030年）
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • デンマーク
    • ノルウェー
  • アジア太平洋
    • アジア太平洋のIn-vitro（体外）毒性試験市場の推定・予測（2018年～2030年）
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカのIn-vitro（体外）毒性試験市場の推定・予測（2018年～2030年）
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカのIn-vitro（体外）毒性試験市場の推定・予測（2018年～2030年）
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • クウェート

第10章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業の分類
  • 企業の市場シェア分析（2023年）
  • 企業ヒートマップ分析
  • 戦略マッピング
    • 事業拡大
    • 合併と買収
    • パートナーシップとコラボレーション
    • 新製品の発売
    • 研究開発
  • 企業プロファイル
    • Charles River Laboratories International, Inc
    • SGS SA
    • Merck KGaA
    • Eurofins Scientific
    • Abbott Laboratories
    • Laboratory Corporation of America Holdings
    • Evotec SE
    • Thermo Fisher Scientific, Inc.
    • Quest Diagnostics Incorporated
    • Agilent Technologies, Inc.
    • Catalent, Inc.
    • Danaher
    • Bio-Rad Laboratories, Inc
    • BioIVT
    • Gentronix
図表

List of Tables

  • Table 1 In-vitro toxicology testing market 2018 - 2030 (USD Million)
  • Table 2 Global market estimates and forecasts by region, 2018 - 2030 (USD Million)
  • Table 3 Global market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 4 Global market estimates and forecasts by method, 2018 - 2030 (USD Million)
  • Table 5 Global market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 6 Global market estimates and forecasts by technology, 2018 - 2030 (USD Million)
  • Table 7 Global market estimates and forecasts by end-use, 2018 - 2030 (USD Million)
  • Table 8 In-vitro toxicology testing- M&A, collaborations & partnership scenario
  • Table 9 Cell Culture Technology market by region, 2018 - 2030 (USD Million)
  • Table 10 High Throughput Technology market by region, 2018 - 2030 (USD Million)
  • Table 11 Molecular Imaging market by region, 2018 - 2030 (USD Million)
  • Table 12 AI Deep Learning market by region, 2018 - 2030 (USD Million)
  • Table 13 OMICS Technology market by region, 2018 - 2030 (USD Million)
  • Table 14 Consumables market by region, 2018 - 2030 (USD Million)
  • Table 15 Assays market by region, 2018 - 2030 (USD Million)
  • Table 16 Instruments market by region, 2018 - 2030 (USD Million)
  • Table 17 Software market by region, 2018 - 2030 (USD Million)
  • Table 18 Services market by region, 2018 - 2030 (USD Million)
  • Table 19 Systemic Toxicology market by region, 2018 - 2030 (USD Million)
  • Table 20 Acute Toxicity market by region, 2018 - 2030 (USD Million)
  • Table 21 Carcinogenicity market by region, 2018 - 2030 (USD Million)
  • Table 22 Developmental Toxicity market by region, 2018 - 2030 (USD Million)
  • Table 23 Others market by region, 2018 - 2030 (USD Million)
  • Table 24 Dermal Toxicity market by region, 2018 - 2030 (USD Million)
  • Table 25 Skin Irritation Test market by region, 2018 - 2030 (USD Million)
  • Table 26 Skin Sensitization Test market by region, 2018 - 2030 (USD Million)
  • Table 27 Skin Corrosion Test market by region, 2018 - 2030 (USD Million)
  • Table 28 Phototoxicity Test market by region, 2018 - 2030 (USD Million)
  • Table 29 Dermal Toxicity market by region, 2018 - 2030 (USD Million)
  • Table 30 Others market by region, 2018 - 2030 (USD Million)
  • Table 31 Endocrine Disruption market by region, 2018 - 2030 (USD Million)
  • Table 32 Dioxins market by region, 2018 - 2030 (USD Million)
  • Table 33 Skin Sensitization Test market by region, 2018 - 2030 (USD Million)
  • Table 34 Phthalates market by region, 2018 - 2030 (USD Million)
  • Table 35 Phototoxicity Test market by region, 2018 - 2030 (USD Million)
  • Table 36 Polychlorinated biphenyls (PCB) market by region, 2018 - 2030 (USD Million)
  • Table 37 Occular Toxicity market by region, 2018 - 2030 (USD Million)
  • Table 38 Intravitreal market by region, 2018 - 2030 (USD Million)
  • Table 39 Subretinal market by region, 2018 - 2030 (USD Million)
  • Table 40 Others market by region, 2018 - 2030 (USD Million)
  • Table 41 Other Toxicity Test market by region, 2018 - 2030 (USD Million)
  • Table 42 Immunotoxicity market by region, 2018 - 2030 (USD Million)
  • Table 43 Reproductive Toxicity market by region, 2018 - 2030 (USD Million)
  • Table 44 Neurotoxicity market by region, 2018 - 2030 (USD Million)
  • Table 45 Epigenetic Alterations market by region, 2018 - 2030 (USD Million)
  • Table 46 Genotoxicity market by region, 2018 - 2030 (USD Million)
  • Table 47 Others market by region, 2018 - 2030 (USD Million)
  • Table 48 Cellular Assay market by region, 2018 - 2030 (USD Million)
  • Table 49 Live Cells market by region, 2018 - 2030 (USD Million)
  • Table 50 High Throughput / High Content Screening market by region, 2018 - 2030 (USD Million)
  • Table 51 Molecular Imaging market by region, 2018 - 2030 (USD Million)
  • Table 52 Confocal Microscopy market by region, 2018 - 2030 (USD Million)
  • Table 53 Others market by region, 2018 - 2030 (USD Million)
  • Table 54 Biochemical Assay market by region, 2018 - 2030 (USD Million)
  • Table 55 In-silico market by region, 2018 - 2030 (USD Million)
  • Table 56 Ex-vivo market by region, 2018 - 2030 (USD Million)
  • Table 57 Pharmaceutical Industry market by region, 2018 - 2030 (USD Million)
  • Table 58 Cosmetics & Household Products market by region, 2018 - 2030 (USD Million)
  • Table 59 Academic Institutes & Research Laboratories market by region, 2018 - 2030 (USD Million)
  • Table 60 Diagnostics market by region, 2018 - 2030 (USD Million)
  • Table 61 Medical Devices market by region, 2018 - 2030 (USD Million)
  • Table 62 Others market by region, 2018 - 2030 (USD Million)
  • Table 63 Chemicals Industry market by region, 2018 - 2030 (USD Million)
  • Table 64 Food Industry market by region, 2018 - 2030 (USD Million)
  • Table 65 North America In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 66 North America In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 67 North America In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 68 North America In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
  • Table 69 North America In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 70 U.S. In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 71 U.S. In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 72 U.S. In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 73 U.S. In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 74 U.S. In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 75 Canada In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 76 Canada In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 77 Canada In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 78 Canada In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 79 Canada In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 80 Europe In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 81 Europe In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 82 Europe In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 83 Europe In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
  • Table 84 Europe In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 85 Germany In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 86 Germany In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 87 Germany In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 88 Germany In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 89 Germany In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 90 UK In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 91 UK In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 92 UK In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 93 UK In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 94 UK In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 95 France In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 96 France In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 97 France In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 98 France In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
  • Table 99 France In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 100 Italy In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 101 Italy In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 102 Italy In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 103 Italy In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 104 Italy In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 105 Spain In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 106 Spain In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 107 Spain In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 108 Spain In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 109 Spain In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 110 Sweden In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 111 Sweden In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 112 Sweden In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 113 Sweden In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
  • Table 114 Sweden In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 115 Denmark In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 116 Denmark In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 117 Denmark In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 118 Denmark In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 119 Denmark In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 120 Norway In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 121 Norway In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 122 Norway In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 123 Norway In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 124 Norway In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 125 Asia Pacific In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 126 Asia Pacific In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 127 Asia Pacific In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 128 Asia Pacific In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
  • Table 129 Asia Pacific In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 130 Japan In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 131 Japan In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 132 Japan In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 133 Japan In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 134 Japan In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 135 China In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 136 China In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 137 China In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 138 China In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 139 China In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 140 India In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 141 India In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 142 India In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 143 India In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
  • Table 144 India In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 145 Australia In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 146 Australia In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 147 Australia In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 148 Australia In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 149 Australia In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 150 South Korea In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 151 South Korea In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 152 South Korea In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 153 South Korea In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 154 South Korea In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 155 Thailand In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 156 Thailand In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 157 Thailand In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 158 Thailand In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
  • Table 159 Thailand In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 160 Latin America In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 161 Latin America In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 162 Latin America In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 163 Latin America In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 164 Latin America In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 165 Brazil In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 166 Brazil In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 167 Brazil In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 168 Brazil In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 169 Brazil In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 170 Mexico In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 171 Mexico In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 172 Mexico In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 173 Mexico In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 174 Mexico In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 175 Argentina In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 176 Argentina In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 177 Argentina In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 178 Argentina In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 179 Argentina In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 180 Middle East and Africa In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 181 Middle East and Africa In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 182 Middle East and Africa In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 183 Middle East and Africa In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
  • Table 184 Middle East and Africa In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 185 South Africa In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 186 South Africa In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 187 South Africa In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 188 South Africa In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 189 South Africa In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 190 Saudi Arabia In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 191 Saudi Arabia In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 192 Saudi Arabia In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 193 Saudi Arabia In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 194 Saudi Arabia In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 195 UAE In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 196 UAE In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 197 UAE In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 198 UAE In-vitro toxicology testing market by method, 2018 - 2030 (USD Million)
  • Table 199 UAE In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)
  • Table 200 Kuwait In-vitro toxicology testing market by product, 2018 - 2030 (USD Million)
  • Table 201 Kuwait In-vitro toxicology testing market by technology, 2018 - 2030 (USD Million)
  • Table 202 Kuwait In-vitro toxicology testing market by method 2018 - 2030 (USD Million)
  • Table 203 Kuwait In-vitro toxicology testing market by application, 2018 - 2030 (USD Million)
  • Table 204 Kuwait In-vitro toxicology testing market by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Figure 1 Market research process
  • Figure 2 Information Procurement
  • Figure 3 Primary Research Pattern
  • Figure 4 Market Research Approaches
  • Figure 5 Value Chain-Based Sizing & Forecasting
  • Figure 6 Market Formulation & Validation
  • Figure 7 In-vitro Toxicology Testing, Market Segmentation
  • Figure 8 Market Snapshot, 2023
  • Figure 9 Market Trends & Outlook
  • Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Figure 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Figure 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Figure 14 Porter's Five Forces Analysis
  • Figure 15 Global In-vitro Toxicology Testing Market: Product Movement Analysis
  • Figure 16 Global In-vitro Toxicology Testing Market, for Consumables,2018 - 2030 (USD Million)
  • Figure 17 Global In-vitro Toxicology Testing Market, for Assays,2018 - 2030 (USD Million)
  • Figure 18 Global In-vitro Toxicology Testing Market, for Instruments,2018 - 2030 (USD Million)
  • Figure 19 Global In-vitro Toxicology Testing Market, for Software,2018 - 2030 (USD Million)
  • Figure 20 Global In-vitro Toxicology Testing Market, for Services,2018 - 2030 (USD Million)
  • Figure 21 Global In-vitro Toxicology Testing Market Market: Application Movement Analysis
  • Figure 22 Global In-vitro Toxicology Testing Market, for Systemic Toxicology,2018 - 2030 (USD Million)
  • Figure 23 Global In-vitro Toxicology Testing Market, for Acute Toxicity,2018 - 2030 (USD Million)
  • Figure 24 Global In-vitro Toxicology Testing Market, for Carcinogenicity,2018 - 2030 (USD Million)
  • Figure 25 Global In-vitro Toxicology Testing Market, for Developmental Toxicity,2018 - 2030 (USD Million)
  • Figure 26 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030 (USD Million)
  • Figure 27 Global In-vitro Toxicology Testing Market, for Dermal Toxicity,2018 - 2030 (USD Million)
  • Figure 28 Global In-vitro Toxicology Testing Market, for Skin Irritation Test,2018 - 2030 (USD Million)
  • Figure 29 Global In-vitro Toxicology Testing Market, for Skin Sensitization Test,2018 - 2030 (USD Million)
  • Figure 30 Global In-vitro Toxicology Testing Market, for Skin Corrosion Test,2018 - 2030 (USD Million)
  • Figure 31 Global In-vitro Toxicology Testing Market, for Phototoxicity Test,2018 - 2030 (USD Million)
  • Figure 32 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030 (USD Million)
  • Figure 33 Global In-vitro Toxicology Testing Market, for Endocrine Disruption,2018 - 2030 (USD Million)
  • Figure 34 Global In-vitro Toxicology Testing Market, for Dioxins,2018 - 2030 (USD Million)
  • Figure 35 Global In-vitro Toxicology Testing Market, for Phthalates,2018 - 2030 (USD Million)
  • Figure 36 Global In-vitro Toxicology Testing Market, for Polychlorinated biphenyls (PCB),2018 - 2030 (USD Million)
  • Figure 37 Global In-vitro Toxicology Testing Market, for Occular Toxicity,2018 - 2030 (USD Million)
  • Figure 38 Global In-vitro Toxicology Testing Market, for Intravitreal,2018 - 2030 (USD Million)
  • Figure 39 Global In-vitro Toxicology Testing Market, for Subretinal,2018 - 2030 (USD Million)
  • Figure 40 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030 (USD Million)
  • Figure 41 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030 (USD Million)
  • Figure 42 Global In-vitro Toxicology Testing Market, for Immunotoxicity,2018 - 2030 (USD Million)
  • Figure 43 Global In-vitro Toxicology Testing Market, for Reproductive Toxicity,2018 - 2030 (USD Million)
  • Figure 44 Global In-vitro Toxicology Testing Market, for Neurotoxicity,2018 - 2030 (USD Million)
  • Figure 45 Global In-vitro Toxicology Testing Market, for Epigenetic Alterations,2018 - 2030 (USD Million)
  • Figure 46 Global In-vitro Toxicology Testing Market, for Genotoxicity,2018 - 2030 (USD Million)
  • Figure 47 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030 (USD Million)
  • Figure 48 Global In-vitro Toxicology Testing Market, : Method Movement Analysis
  • Figure 49 Global In-vitro Toxicology Testing Market, for Cellular Assay,2018 - 2030 (USD Million)
  • Figure 50 Global In-vitro Toxicology Testing Market, for Live Cells,2018 - 2030 (USD Million)
  • Figure 51 Global In-vitro Toxicology Testing Market, for High Throughput / High Content Screening,2018 - 2030 (USD Million)
  • Figure 52 Global In-vitro Toxicology Testing Market, for Molecular Imaging,2018 - 2030 (USD Million)
  • Figure 53 Global In-vitro Toxicology Testing Market, for Confocal Microscopy,2018 - 2030 (USD Million)
  • Figure 54 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030 (USD Million)
  • Figure 55 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030 (USD Million)
  • Figure 56 Global In-vitro Toxicology Testing Market, for Fixed Cells,2018 - 2030 (USD Million)
  • Figure 57 Global In-vitro Toxicology Testing Market, for Biochemical Assay,2018 - 2030 (USD Million)
  • Figure 58 Global In-vitro Toxicology Testing Market, for In-silico ,2018 - 2030 (USD Million)
  • Figure 59 Global In-vitro Toxicology Testing Market, for Ex-vivo,2018 - 2030 (USD Million)
  • Figure 60 Global In-vitro Toxicology Testing Market: Technology Movement Analysis
  • Figure 61 Global In-vitro Toxicology Testing Market, for Cell Culture Technology,2018 - 2030 (USD Million)
  • Figure 62 Global In-vitro Toxicology Testing Market, for High Throughput Technology,2018 - 2030 (USD Million)
  • Figure 63 Global In-vitro Toxicology Testing Market, for Molecular Imaging,2018 - 2030 (USD Million)
  • Figure 64 Global In-vitro Toxicology Testing Market, for OMICS Technology,2018 - 2030 (USD Million)
  • Figure 65 Global In-vitro Toxicology Testing Market: End-Use Movement Analysis
  • Figure 66 Global In-vitro Toxicology Testing Market, for Pharmaceutical Industry,2018 - 2030 (USD Million)
  • Figure 67 Global In-vitro Toxicology Testing Market, for Cosmetics & Household Products,2018 - 2030 (USD Million)
  • Figure 68 Global In-vitro Toxicology Testing Market, for Academic Institutes & Research Laboratories,2018 - 2030 (USD Million)
  • Figure 69 Global In-vitro Toxicology Testing Market, for Diagnostics,2018 - 2030 (USD Million)
  • Figure 70 Global In-vitro Toxicology Testing Market, for Medical Devices,2018 - 2030 (USD Million)
  • Figure 71 Global In-vitro Toxicology Testing Market, for Others,2018 - 2030 (USD Million)
  • Figure 72 Global In-vitro Toxicology Testing Market, for Chemicals Industry,2018 - 2030 (USD Million)
  • Figure 73 Global In-vitro Toxicology Testing Market, for Food Industry ,2018 - 2030 (USD Million)
  • Figure 74 Regional Marketplace: Key Takeaways
  • Figure 75 Regional Outlook, 2023 & 2030
  • Figure 76 Global In-vitro Toxicology Testing Market: Region Movement Analysis
  • Figure 77 North America In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 78 U.S. In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 79 Canada In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 80 Europe In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 81 Germany In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 82 UK In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 83 France In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 84 Italy In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 85 Spain In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 86 Sweden In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 87 Denmark In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 88 Norway In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 89 Asia Pacific In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 90 Japan In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 91 China In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 92 India In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 93 Australia In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 94 South Korea In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 95 Thailand In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 96 Latin America In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 97 Brazil In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 98 Mexico In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 99 Argentina In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 100 Middle East and Africa In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 101 South Africa In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 102 Saudi Arabia In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 103 UAE In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Figure 104 Kuwait In-vitro Toxicology Testing Market, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-847-3

In-vitro Toxicology Testing Market Growth & Trends:

The global in-vitro toxicology testing market size is expected to reach USD 64.81 billion by 2030, registering a CAGR of 11.17% from 2024 to 2030, according to a new report by Grand View Research, Inc. Over the years, acceptance of in-vitro toxicology testing methods by regulatory authorities is increasing at a faster pace & thus validation of these tests methods opposed to conventional testing is even rising. Also, development of technologies to substitute animal use for toxicology tests has fueled the usage of in-vitro models such as in-silico simulation, assays, 3D cell cultures and many more, thereby boosting market growth.

Screening of a new drug candidate involves the use of animals for preclinical studies which is very tedious and expensive. However, in recent times, several jurisdictions are promoting ban for animal-based chemical testing. For example, for several years, the EU has been promoting the reduction, replacement, and refinement of animal tests. The Regulation on cosmetic products (1223/2009), REACH (2007/2006), the Directive on the protection of animals used for scientific purposes (2010/63), and Classification, Labelling and Packaging (CLP) (1272/2008) are some examples of EU legislation that are engaged in strongly encouraging the replacement of animal toxicology testing. Furthermore, in June 2018, the Cruelty-Free Cosmetics Act was passed in California to ban the selling of animal-tested products after 2020.

Many governments and private organization are taking actions to minimize conventional testing models, providing funds to support & develop in-vitro toxicology assays and form conducive government policies. Thus, increase in government initiatives that are focused on banning animal testing can be attributed to the rise in adoption of in-vitro toxicological models and creates many opportunities within the market. For instance, approximately USD 3.2 million were contributed by People for the Ethical Treatment of Animals (PETA) and its international associates to promote the development of non-animal test methods.

The advancements in computational and screening methods such as biological, high throughput, and chemical coupled with the vast number of public databases for toxicity analysis has expanded largely. This has allowed researchers to access information for drug discovery studies, toxicology profiling, and drug development programs. For instance, the MetaTox HS project by Agilent Technologies, Inc. brings advanced solutions for toxicity assays & high sensitivity metabolism during drug development procedures.

In-vitro Toxicology Testing Market Report Highlights:

  • Based on technology, Cell culture technology segment held a dominant market share of 43.88% in the global market in 2023, owing to the increased demand for accurate & cost-effective analysis. Moreover, the adoption of 3D cell culture is also propelling the growth of this segment
  • On the basis of application, the systemic toxicology application segment dominated the market in 2023. Generation of toxicology data points such as minimum dose, tolerated dose, risk assessment and many more will contribute to the revenue generation
  • The cellular assay accounted for the largest share in terms of revenue and is expected to grow over the forecasted period, owing to the developments in cell-based imaging assays, high throughput screening & label-free detection
  • The pharmaceutical industry end-use segment held a major share in the market in 2023. The importance of toxicology testing during drug development stages coupled with high number of product pipeline attributes to the revenue generation
  • North America dominated the market and accounted for a 47.73% share in 2023 due to prevalence of animal testing bans & supportive government initiatives for toxicology research. In addition, aggregation of players in this regions to provide in-vitro testing product and services will continue the revenue generation during the forecast

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. In-vitro Toxicology Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rise in government funding for toxicology research
      • 3.2.1.2. Opposition in animal testing
      • 3.2.1.3. Ongoing developments in advanced toxicology research
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Lack of in-vitro models
      • 3.2.2.2. Issues pertaining to standardization of in vitro studies
  • 3.3. In-vitro Toxicology Testing Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape
    • 3.3.3. Pricing Analysis

Chapter 4. In-vitro Toxicology Testing Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. In-vitro Toxicology Testing Market: Technology Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Cell Culture Technology
    • 4.3.1. Cell Culture Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. High Throughput Technology
    • 4.4.1. High Throughput Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Molecular Imaging
    • 4.5.1. Molecular Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. OMICS Technology
    • 4.6.1. OMICS Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. In-vitro Toxicology Testing Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. In-vitro Toxicology Testing Market: Product Movement Analysis, USD Million, 2023 & 2030
  • 5.3. Consumables
    • 5.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Assays
    • 5.4.1. Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Instruments
    • 5.5.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Software
    • 5.6.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Services
    • 5.7.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. In-vitro Toxicology Testing Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. In-vitro Toxicology Testing Market: Application Movement Analysis, USD Million, 2023 & 2030
  • 6.3. Systemic Toxicology
    • 6.3.1. Systemic Toxicology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.3.1.1. Acute Toxicity
      • 6.3.1.1.1. Acute Toxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.3.1.2. Carcinogenicity
      • 6.3.1.2.1. Carcinogenicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.3.1.3. Developmental Toxicity
      • 6.3.1.3.1. Developmental Toxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.3.1.4. Others
      • 6.3.1.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Dermal Toxicity
    • 6.4.1. Dermal Toxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.4.1.1. Skin Irritation Test
      • 6.4.1.1.1. Skin Irritation Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.4.1.2. Skin Sensitization Test
      • 6.4.1.2.1. Skin Sensitization Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.4.1.3. Skin Corrosion Test
      • 6.4.1.3.1. Skin Corrosion Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.4.1.4. Phototoxicity Test
      • 6.4.1.4.1. Phototoxicity Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.4.1.5. Others
      • 6.4.1.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Endocrine Disruption
    • 6.5.1. Endocrine Disruption Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.1.1. Dioxins
      • 6.5.1.1.1. Dioxins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.1.2. Phthalates
      • 6.5.1.2.1. Phthalates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.1.3. Polychlorinated biphenyls (PCB)
      • 6.5.1.3.1. Polychlorinated biphenyls (PCB) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Ocular Toxicity
    • 6.6.1. Ocular Toxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.1.1. Intravitreal
      • 6.6.1.1.1. Intravitreal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.1.2. Subretinal
      • 6.6.1.2.1. Subretinal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.6.1.3. Others
      • 6.6.1.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Other Toxicity
      • 6.7.1.1. Other Toxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.1.2. Immunotoxicity
      • 6.7.1.2.1. Immunotoxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.1.3. Reproductive Toxicity
      • 6.7.1.3.1. Reproductive Toxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.1.4. Neurotoxicity
      • 6.7.1.4.1. Neurotoxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.1.5. Epigenetic Alterations
      • 6.7.1.5.1. Epigenetic Alterations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.1.6. Genotoxicity
      • 6.7.1.6.1. Genotoxicity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.1.7. Others
      • 6.7.1.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. In-vitro Toxicology Testing Market: Method Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. In-vitro Toxicology Testing Market: Method Movement Analysis, USD Million, 2023 & 2030
  • 7.3. Cellular Assay
    • 7.3.1. Cellular Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.1.1. Live Cells
      • 7.3.1.1.1. Live Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.1.1.1.1. High Throughput / High Content Screening
      • 7.3.1.1.1.1.1. High Throughput / High Content Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.1.1.1.2. Molecular Imaging
      • 7.3.1.1.1.2.1. Molecular Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.1.1.1.2.1.1. Confocal Microscopy
      • 7.3.1.1.1.2.1.1.1. Confocal Microscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.1.1.1.2.1.2. Others
      • 7.3.1.1.1.2.1.2.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.1.1.1.3. Others
      • 7.3.1.1.1.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 7.3.1.2. Fixed Cells
      • 7.3.1.2.1. Fixed Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Biochemical Assay
    • 7.4.1. Biochemical Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. In-silico
    • 7.5.1. In-silico Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Ex-vivo
    • 7.6.1. Ex-vivo Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. In-vitro Toxicology Testing Market: End-Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. In-vitro Toxicology Testing Market: End-Use Movement Analysis, USD Million, 2023 & 2030
  • 8.3. Pharmaceutical Industry
    • 8.3.1. Pharmaceutical Industry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Cosmetics & Household Products
    • 8.4.1. Cosmetics & Household Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Academic Institutes & Research Laboratories
    • 8.5.1. Academic Institutes & Research Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Diagnostics
    • 8.6.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.1.1. Medical Devices
      • 8.6.1.1.1. Medical Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.1.2. Others
      • 8.6.1.2.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Chemicals Industry
    • 8.7.1. Chemicals Industry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Food Industry
    • 8.8.1. Food Industry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. In-vitro Toxicology Testing Market: Regional Estimates & Trend Analysis

  • 9.1. In-vitro Toxicology Testing Market Share, By Region, 2023 & 2030, USD Million
  • 9.2. North America
    • 9.2.1. North America In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. UK In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7. Sweden
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Sweden In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Denmark In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. China
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. China In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Japan In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. South Korea In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Australia In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. Thailand In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Mexico In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.4.3. Competitive Insights
      • 9.5.4.4. Argentina In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Saudi Arabia In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. UAE
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. UAE In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. South Africa
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. South Africa In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait In-vitro Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Market Share Analysis, 2023
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. Charles River Laboratories International, Inc
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. SGS S.A
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. Merck KGaA
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. Eurofins Scientific
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. Abbott Laboratories
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. Laboratory Corporation of America Holdings
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Evotec S.E
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. Thermo Fisher Scientific, Inc.
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Quest Diagnostics Incorporated
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Agilent Technologies, Inc.
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments
    • 10.6.11. Catalent, Inc.
      • 10.6.11.1. Participant's Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Recent Developments
    • 10.6.12. Danaher
      • 10.6.12.1. Participant's Overview
      • 10.6.12.2. Financial Performance
      • 10.6.12.3. Product Benchmarking
      • 10.6.12.4. Recent Developments
    • 10.6.13. Bio-Rad Laboratories, Inc
      • 10.6.13.1. Participant's Overview
      • 10.6.13.2. Financial Performance
      • 10.6.13.3. Product Benchmarking
      • 10.6.13.4. Recent Developments
    • 10.6.14. BioIVT
      • 10.6.14.1. Participant's Overview
      • 10.6.14.2. Financial Performance
      • 10.6.14.3. Product Benchmarking
      • 10.6.14.4. Recent Developments
    • 10.6.15. Gentronix
      • 10.6.15.1. Participant's Overview
      • 10.6.15.2. Financial Performance
      • 10.6.15.3. Product Benchmarking
      • 10.6.15.4. Recent Developments